Author Correction: PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 05 2019
Historique:
entrez: 23 5 2019
pubmed: 23 5 2019
medline: 23 5 2019
Statut: epublish

Résumé

This Article contains an error in Figure 3. In panel g, images representing miR-222-TuD and miR-424-TuD were both taken from the miR-222-TuD image. The correct version of Figure 3 is shown in the accompanying Author Correction.

Identifiants

DOI: 10.1038/s41467-019-10052-z PMID: 31113949 PMC: PMC6529421
pubmed: 31113949
doi: 10.1038/s41467-019-10052-z
pii: 10.1038/s41467-019-10052-z
pmc: PMC6529421
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Pagination

2259

Commentaires et corrections

Type : ErratumFor

Auteurs

Haibo Han (H)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Yantao Du (Y)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Wei Zhao (W)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Sheng Li (S)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Dongji Chen (D)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.

Jing Zhang (J)

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.

Jiang Liu (J)

Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.

Zhenhe Suo (Z)

Department of Pathology, Oslo University Hospital, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, 0379, Norway.

Xiuwu Bian (X)

Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.

Baocai Xing (B)

Department of Hepatobiliary Surgery I, Peking University Cancer Hospital and Institute, Beijing, 100142, China.

Zhiqian Zhang (Z)

Department of Cell Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular and Translational Medicine, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China. zlzqzhang@bjmu.edu.cn.

Classifications MeSH